These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 12110816

  • 1. The risk of hospitalization in patients with asthma switched from an inhaled corticosteroid to a leukotriene receptor antagonist.
    Stempel DA, Pinto L, Stanford RH.
    J Allergy Clin Immunol; 2002 Jul; 110(1):39-41. PubMed ID: 12110816
    [Abstract] [Full Text] [Related]

  • 2. Observational study of the effects of using montelukast vs fluticasone in patients matched at baseline.
    Allen-Ramey FC, Duong PT, Riedel AA, Markson LE, Weiss KB.
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):373-80. PubMed ID: 15521374
    [Abstract] [Full Text] [Related]

  • 3. Fluticasone is associated with lower asthma-related costs than leukotriene modifiers in a real-world analysis.
    Armstrong EP, Malone DC.
    Pharmacotherapy; 2002 Sep; 22(9):1117-23. PubMed ID: 12222547
    [Abstract] [Full Text] [Related]

  • 4. Asthma: resource use and costs for inhaled corticosteroid vs leukotriene modifier treatment--a meta-analysis.
    Halpern MT, Khan ZM, Stanford RH, Spayde KM, Golubiewski M.
    J Fam Pract; 2003 May; 52(5):382-9. PubMed ID: 12737772
    [Abstract] [Full Text] [Related]

  • 5. Fluticasone propionate compared with zafirlukast in controlling persistent asthma: a randomized double-blind, placebo-controlled trial.
    Busse W, Wolfe J, Storms W, Srebro S, Edwards L, Johnson M, Bowers BW, Rogenes PR, Rickard K.
    J Fam Pract; 2001 Jul; 50(7):595-602. PubMed ID: 11485708
    [Abstract] [Full Text] [Related]

  • 6. Economic impact of asthma therapy with fluticasone propionate, montelukast, or zafirlukast in a managed care population.
    Pathak DS, Davis EA, Stanford RH.
    Pharmacotherapy; 2002 Feb; 22(2):166-74. PubMed ID: 11837555
    [Abstract] [Full Text] [Related]

  • 7. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma.
    Ducharme FM, Hicks GC.
    Cochrane Database Syst Rev; 2000 Feb; (3):CD002314. PubMed ID: 10908555
    [Abstract] [Full Text] [Related]

  • 8. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children.
    Ng D, Salvio F, Hicks G.
    Cochrane Database Syst Rev; 2004 Feb; (2):CD002314. PubMed ID: 15106175
    [Abstract] [Full Text] [Related]

  • 9. Leukotriene modifier use and asthma severity: how is a new medication being used by adults with asthma?
    Snyder L, Blanc PD, Katz PP, Yelin EH, Eisner MD.
    Arch Intern Med; 2004 Mar 22; 164(6):617-22. PubMed ID: 15037489
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparative evaluation of the leukotriene receptor antagonist pranlukast versus the steroid inhalant fluticasone in the therapy of aged patients with mild bronchial asthma.
    Horiguchi T, Tachikawa S, Kondo R, Miyazaki J, Shiga M, Hirose M, Kobayashi K, Hayashi N, Ohira D, Nasu T, Otake Y, Hata H.
    Arzneimittelforschung; 2007 Mar 22; 57(2):87-91. PubMed ID: 17396618
    [Abstract] [Full Text] [Related]

  • 14. Leukotriene modifier vs inhaled corticosteroid in mild-to-moderate asthma: clinical and anti-inflammatory effects.
    Perng DW, Huang HY, Lee YC, Perng RP.
    Chest; 2004 May 22; 125(5):1693-9. PubMed ID: 15136378
    [Abstract] [Full Text] [Related]

  • 15. Inhaled steroid therapy and hospitalization for bronchial asthma: trend in Tokushima University Hospital.
    Yanagawa H, Shiraga M, Nakamura Y, Azuma M, Yoneda K, Ogawa H, Kitamuro C, Maeda K, Miki M, Matsumori Y, Sugita A, Hashimoto S, Hara C, Tani K, Sone S.
    J Med Invest; 2003 Feb 22; 50(1-2):72-7. PubMed ID: 12630571
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.